Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $891000.0.

  • Atara Biotherapeutics' Amortizatization of Intangibles fell 1803.13% to $891000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 1447.09%. This contributed to the annual value of $4.1 million for FY2024, which is 1425.29% down from last year.
  • Latest data reveals that Atara Biotherapeutics reported Amortizatization of Intangibles of $891000.0 as of Q3 2025, which was down 1803.13% from $957000.0 recorded in Q2 2025.
  • In the past 5 years, Atara Biotherapeutics' Amortizatization of Intangibles registered a high of $1.3 million during Q3 2023, and its lowest value of -$498000.0 during Q1 2022.
  • In the last 4 years, Atara Biotherapeutics' Amortizatization of Intangibles had a median value of $957000.0 in 2025 and averaged $705133.3.
  • Per our database at Business Quant, Atara Biotherapeutics' Amortizatization of Intangibles soared by 222600.0% in 2023 and then plummeted by 1854.68% in 2025.
  • Atara Biotherapeutics' Amortizatization of Intangibles (Quarter) stood at -$50000.0 in 2022, then soared by 2226.0% to $1.1 million in 2023, then fell by 12.61% to $929000.0 in 2024, then dropped by 4.09% to $891000.0 in 2025.
  • Its last three reported values are $891000.0 in Q3 2025, $957000.0 for Q2 2025, and $852000.0 during Q1 2025.